MacConnell Andrew B, Price Alexander K, Paegel Brian M
Department of Chemistry and ‡Doctoral Program in Chemical and Biological Sciences, The Scripps Research Institute , 130 Scripps Way, Jupiter, Florida 33458, United States.
ACS Comb Sci. 2017 Mar 13;19(3):181-192. doi: 10.1021/acscombsci.6b00192. Epub 2017 Feb 22.
DNA-encoded synthesis is rekindling interest in combinatorial compound libraries for drug discovery and in technology for automated and quantitative library screening. Here, we disclose a microfluidic circuit that enables functional screens of DNA-encoded compound beads. The device carries out library bead distribution into picoliter-scale assay reagent droplets, photochemical cleavage of compound from the bead, assay incubation, laser-induced fluorescence-based assay detection, and fluorescence-activated droplet sorting to isolate hits. DNA-encoded compound beads (10-μm diameter) displaying a photocleavable positive control inhibitor pepstatin A were mixed (1920 beads, 729 encoding sequences) with negative control beads (58 000 beads, 1728 encoding sequences) and screened for cathepsin D inhibition using a biochemical enzyme activity assay. The circuit sorted 1518 hit droplets for collection following 18 min incubation over a 240 min analysis. Visual inspection of a subset of droplets (1188 droplets) yielded a 24% false discovery rate (1166 pepstatin A beads; 366 negative control beads). Using template barcoding strategies, it was possible to count hit collection beads (1863) using next-generation sequencing data. Bead-specific barcodes enabled replicate counting, and the false discovery rate was reduced to 2.6% by only considering hit-encoding sequences that were observed on >2 beads. This work represents a complete distributable small molecule discovery platform, from microfluidic miniaturized automation to ultrahigh-throughput hit deconvolution by sequencing.
DNA编码合成正在重新激发人们对用于药物发现的组合化合物库以及用于自动化和定量库筛选技术的兴趣。在此,我们披露了一种能够对DNA编码化合物珠进行功能筛选的微流控电路。该装置可将库珠分配到皮升规模的测定试剂液滴中,从珠子上光化学切割化合物,进行测定孵育,基于激光诱导荧光的测定检测,以及荧光激活液滴分选以分离命中物。将展示可光切割阳性对照抑制剂胃蛋白酶抑制剂A的DNA编码化合物珠(直径10μm)(1920个珠子,729个编码序列)与阴性对照珠(58000个珠子,1728个编码序列)混合,并使用生化酶活性测定法筛选组织蛋白酶D抑制作用。在240分钟的分析过程中,经过18分钟孵育后,该电路分选了1518个命中液滴进行收集。对一部分液滴(1188个液滴)进行目视检查得出错误发现率为24%(1166个胃蛋白酶抑制剂A珠;366个阴性对照珠)。使用模板条形码策略,可以利用下一代测序数据对命中收集珠(1863个)进行计数。珠子特异性条形码实现了重复计数,并且通过仅考虑在>2个珠子上观察到的命中编码序列,错误发现率降低到了2.6%。这项工作代表了一个完整的可分发小分子发现平台,从微流控小型自动化到通过测序进行的超高通量命中物反卷积。